Nutraplus India's Financial Straits Deepen: Narrowed Loss Amid Zero Revenue and Seized Assets

Nutraplus India reported a standalone net loss of ₹0.83 Lacs for the quarter ended September 30, 2023. Total income for the period was nil. The company's full-year loss for FY23 stood at ₹16.71 Lacs, underscoring its complete operational shutdown.

Q3 FY24 and FY23 Financial Results

Nutraplus India Ltd. disclosed its financial results for the quarter ended September 30, 2023 (Q3 FY24) and the full fiscal year ended March 31, 2023 (FY23).

For Q3 FY24, the company reported a standalone net loss of ₹0.83 Lacs, a reduction from the ₹11.00 Lacs loss in the prior year's quarter. Total standalone income remained nil (₹0.00 Cr). Standalone expenditure decreased to ₹0.83 Lacs from ₹11.00 Lacs year-on-year.

The full fiscal year ending March 31, 2023, saw Nutraplus India post a standalone net loss of ₹16.71 Lacs on nil total income, with total expenditure also at ₹16.71 Lacs.

Dire Financial State

These results highlight Nutraplus India's severely compromised operational status, suggesting a complete halt to its core business activities.

The company's assets, formerly the bedrock of its pharmaceutical ingredient manufacturing, have been seized and auctioned. This underscores its precarious financial condition.

A negative net worth means liabilities far exceed assets, presenting substantial obstacles to any potential revival.

Company Background and Distress

Founded in 1990, Nutraplus India Ltd. originally operated as a producer of Active Pharmaceutical Ingredients (APIs) and specialty chemicals. The company has since fallen into severe financial distress.

It became a Non-Performing Asset (NPA) in FY 2019-20 after substantial loan defaults, notably a ₹76.24 crore default to Saraswat Bank by February 2020. This NPA status led to the seizure and subsequent auction of its property, plant, and equipment under the SARFEASI Act, 2002. Consequently, the company now focuses on consulting and plant setup services, generating no operational revenue from its former manufacturing business.

Shareholder Outlook

Shareholders are left with an entity that lacks operational revenue and the physical assets of its former business.

The company's financial standing is critical, characterized by a negative net worth and accumulated losses.

Auditors have raised significant concerns regarding the company's viability as a 'going concern', alongside ongoing non-compliance with SEBI norms.

Key Risks

• NPA and Asset Seizure: Core manufacturing assets have been lost due to loan defaults, eliminating the company's operational base.
• Negative Net Worth: As of September 30, 2023, the company's net worth was negative ₹5.25 Cr, indicating insolvency.
• Zero Revenue: The complete absence of operational income suggests a defunct business model.
• Auditor Qualifications and Reporting Delays: Auditors have qualified reports due to missing crucial financial data and flagged significant delays in regulatory filings, including Q3 FY24 results released over a year late.
• Regulatory Scrutiny: Past SEBI fines for stock manipulation and ongoing non-compliance risks persist.

Peer Comparison

Identifying direct peers in a similar state of operational collapse with seized assets is difficult, given the severity of Nutraplus India's financial distress and its de-facto operational cessation. The company's situation is exceptionally dire.

Key Financial Metric

• The company's standalone Net Worth was negative ₹5.25 Cr as of September 30, 2023.

What to Track Next

• Future disclosures for any signs of operational revival or restructuring, however unlikely.
• Continued auditor reports, particularly their assessment of the company's 'going concern' status.
• Any regulatory actions from SEBI or exchanges regarding persistent non-compliance.
• The ultimate status of the company as a listed entity, given its operational and financial collapse.